latest news releases from the newsroom
Heidrick & Struggles International, Inc.
Heidrick & Struggles to Release 2008 Second Quarter Results On Wednesday, August 6, 2008
CHICAGO, July 21, 2008 (PRIME NEWSWIRE) -- Heidrick & Struggles International, Inc. (Nasdaq:HSII), the world's premier executive search and leadership consulting firm, today announced that it will release its 2008 second quarter results for the period ended June 30, 2008, on Wednesday, August 6, 2008. The second quarter release and quarterly conference call, previously scheduled for July 29, were moved to August 6 in order to allow the company's new Chief Financial Officer, Scott Krenz, to participate. Mr. Krenz has been transitioning into his role as CFO and acclimating to Heidrick & Struggles since his appointment on June 10, 2008, but does not start full-time with the company until August 4, 2008.
North American Galvanizing & Coatings, Inc.
North American Galvanizing & Coatings Reports Record Second Quarter 2008 Earnings
TULSA, Okla., July 21, 2008 (PRIME NEWSWIRE) -- North American Galvanizing & Coatings, Inc. (Nasdaq:NGA) announced today record earnings for the first six months and the second quarter of 2008. The second quarter of 2008 is the Company's tenth consecutive quarter of record earnings.
Goodwin Biotechnology Incorporated
Goodwin Biotechnology's Manufactured Melanin-Binding Antibody Used in Successful Melanoma Trial
PLANTATION, Fla., July 21, 2008 (PRIME NEWSWIRE) -- Goodwin Biotechnology Inc. (GBI) today announced that the melanin-binding IgM antibody manufactured by the company was used in a successful Phase I clinical trial for the treatment of melanoma. The encouraging results, conducted by Pain Therapeutics, Inc. and its collaborators, were announced earlier this month. GBI was selected to develop the process and produce the preclinical and clinical material for this and future trials.